Rxcurve
HCPCS J2406 · per 10 MG

Injection, oritavancin 10 mg

Products billed under this code include Kimyrsa.

Payment limit per 10 MG, by effective quarter, 2Q22 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2406

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Kimyrsa Melinta Therapeutics, LLC 70842-0225-01 120 $5,327.04

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $44.392 −$3.017 10 MG Injection, oritavancin 10 mg v1, posted September 17, 2026
3Q26 $47.409 +$3.69 10 MG Injection, oritavancin 10 mg v1, posted September 15, 2026
2Q26 $43.719 +$0.66 10 MG Injection, oritavancin 10 mg v1, posted September 15, 2026
1Q26 $43.059 +$0.581 10 MG Injection, oritavancin 10 mg v1, posted September 15, 2026
4Q25 $42.478 +$1.074 10 MG Injection, oritavancin 10 mg v1, posted September 8, 2026
3Q25 $41.404 −$1.361 10 MG Injection, oritavancin 10 mg v1, posted March 10, 2026
2Q25 $42.765 −$0.559 10 MG Injection, oritavancin 10 mg v1, posted March 10, 2026
1Q25 $43.324 +$0.821 10 MG Injection, oritavancin 10 mg v1, posted December 19, 2025
4Q24 $42.503 +$0.569 10 MG Injection, oritavancin 10 mg v1, posted June 11, 2025
3Q24 $41.934 +$1.039 10 MG Injection, oritavancin 10 mg v1, posted June 11, 2025
2Q24 $40.895 −$0.022 10 MG Injection, oritavancin 10 mg v1, posted March 11, 2025
1Q24 $40.917 +$0.223 10 MG Injection, oritavancin 10 mg v1, posted December 19, 2024
4Q23 $40.694 −$1.04 10 MG Injection, oritavancin 10 mg v1, posted October 10, 2024
3Q23 $41.734 −$0.396 10 MG Injection, oritavancin 10 mg v1, posted June 5, 2024
2Q23 $42.13 +$0.721 10 MG Injection, oritavancin 10 mg v1, posted February 23, 2024
1Q23 $41.409 −$0.125 10 MG Injection, oritavancin 10 mg v1, posted December 6, 2023
4Q22 $41.534 −$0.735 10 MG Injection, oritavancin 10 mg v1, posted June 22, 2023
3Q22 $42.269 −$0.111 10 MG Injection, oritavancin 10 mg v1, posted June 9, 2023
2Q22 $42.38 – 10 MG Injection, oritavancin 10 mg v1, posted December 14, 2022

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files